The National Medical Insurance Administration issued a risk warning, and Bayer responded: It is not our company.

On July 7th, the National Medical Insurance Administration issued a "risk warning". Bayer responded: The company mentioned in the relevant reports is not Bayer. Bayer has always strictly complied with national laws and regulations, and has always supported the efforts made by the Chinese government to improve drug accessibility and reduce the burden on patients. Bayer actively supports the work of the National Medical Insurance Administration, especially the centralized procurement initiative that benefits the country and the people. Through continuous cooperation and innovation, Bayer will contribute to the early realization of the "Healthy China 2030" vision.